H. Dabernat
- Topics
- Pneumonia and Respiratory Infections (19 papers)Antibiotic Resistance in Bacteria (19 papers)Bacterial Infections and Vaccines (16 papers)
- Journals
- Clinical Infectious DiseasesJournal of Clinical MicrobiologyAntimicrobial Agents and Chemotherapy
- Partner nations
- FranceUnited StatesLebanon
In The Last Decade
H. Dabernat
42 papers receiving 257 citations
Peers
Comparison fields: 5 of 51
- Epidemiology 143
- Molecular Medicine 139
- Microbiology 87
- Pharmacology 68
- Molecular Biology 41
Countries citing papers authored by H. Dabernat
This map shows the geographic impact of H. Dabernat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Dabernat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Dabernat more than expected).
Fields of papers citing papers by H. Dabernat
This network shows the impact of papers produced by H. Dabernat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Dabernat. The network helps show where H. Dabernat may publish in the future.
Co-authorship network of co-authors of H. Dabernat
This figure shows the co-authorship network connecting the top 25 collaborators of H. Dabernat. A scholar is included among the top collaborators of H. Dabernat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Dabernat. H. Dabernat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 18 | |
| 3 | 25 | |
| 4 | 3 | |
| 5 | 3 | |
| 6 | 9 | |
| 7 | 4 | |
| 8 | 52 | |
| 9 | 8 | |
| 10 | [Resistance to antibiotic treatment produced in a model of experimental Pseudomonas aeruginosa peritonitis]. | 0 |
| 11 | [In vitro antibacterial effect of a new oral cephalosporin, cefixime. Results of a multicenter study]. | 2 |
| 12 | 7 | |
| 13 | 7 | |
| 14 | [Multicenter study of the in vitro effect of imipenem (N-formimidoyl-thienamycin) on hospital bacteria]. | 2 |
| 15 | 1 | |
| 16 | 1 | |
| 17 | 14 | |
| 18 | Comparative activities of cefotaxime, a new cephalosporin derivative, and of selected beta-lactam antibiotics against Haemophilus species. | 5 |
| 19 | Yersinia enterocolitica fermenting rhamnose. About 15 strains isolated in children. | 4 |
| 20 | Groupes d'incompatibilité des plasmides r chez les souches de Salmonella épidémiques. | 4 |
About H. Dabernat
H. Dabernat is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Microbiology, having authored 43 papers that have together received 290 indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (19 papers), Antibiotic Resistance in Bacteria (19 papers) and Bacterial Infections and Vaccines (16 papers). The work is most often cited by research in Molecular Medicine (139 citations), Microbiology (87 citations) and Applied Microbiology and Biotechnology (22 citations). H. Dabernat has collaborated with scholars based in France, United States and Lebanon. Frequent co-authors include C. Delmas, J Lemozy, J. Sirot, D. Sirot, C. Chanal, Roger Labia, D. Tainturier, R. Bauriaud, Clément Delmas and V. Goulet. Their work appears in journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.